Prof. Tsui-Fen Chou
Kerckhoff 225 (ext 6772)
Dr. Tsui-Fen Chou's story begins on the island of Taiwan, where she graduated from National Taiwan University, the country's most prestigious university. She left this tropical climate for the icy lakes of the Midwest, completing a PhD in Medicinal Chemistry at the University of Minnesota. Assuming she had experienced enough snow to last a lifetime, she returned to the tepid climates of Southern California as a post-doctoral fellow in the Deshaies Lab at the California Institute of Technology, wherein she played a pivotal role in the discovery of a new class of potential anti-cancer drugs targeting the enzyme p97.
Building off of her successes, in 2012, Dr. Chou catapulted to a faculty position at LA BioMed, where she was Assistant Professor of Pediatrics, David Geffen School of Medicine, UCLA, Division of Medical Genetics, Harbor-UCLA Medical Center. Dr. Chou is also a member of the Signal Transduction and Therapeutics Program at the Jonsson Comprehensive Cancer Center. She moved her lab to Caltech in September of 2019 and is currently a research professor in the Division of Biology and Biological Engineering.
Dr. Chou is interested in understanding the mechanisms of disease causing mutations of p97/VCP ATPase, a key player in cell proteasome and autophagy function, and has used p97 inhibitors as tools to develop pathway-specific inhibitors. Her main research focus is on discovering underlying mechanisms that may lead to new therapeutic targets for cancer and rare disease. She is an excellent teacher and mentor - dedicating time to train students at every level (high school, college, graduate, etc.) - and is heavily invested in the success of her current and former employees and students. She is generous with her knowledge and enjoys sharing her extensive experience in medicinal chemistry, cancer cell biology, and biological chemistry with a particular interest in proteomics and enzymology.
Dr. Jeff Jones
Beckman Institute 224
Jeff received a B.S. in Microbiology and Biochemistry from CalPoly SLO in 2001, and a Ph.D. in Analytical Chemistry in 2005 from the University of Arkansas under the direction of Prof. Charles Wilkins. While at U of Arkansas, Jeff combined his skills in microbiology with MALDI FTMS to characterize whole cell bacteria by mass spectrometry and developed an appreciation for informatics and software development. He went on to post-doc at the Institute of Genomics and Bioinformatics at UC Irvine working with Prof. Lan Huang to characterize proteasome degradation using the then newly developed high resolution LTQ-OrbiTrap. In 2007 Jeff joined the biotech startup Applied Proteomics Inc. shortly after inception and continued on in various rolls for the next 10 years, building out HPLC and LCMS workflows, developing software and discovering the company's signature colorectal biomarker panel. Just prior to joining the Proteome Exploration Laboratory at Caltech, Jeff had founded an informatics company focused on providing consulting services to the pharmaceutical and biotech industries. In addition, Jeff has developed unique software and automated analysis solutions to high throughput proteomics, has focused on clinical biomarker discovery, and holds 11 patents related to mass spectrometry and proteomics.
Jeff is currently researching a variety of topics in the Proteome Exploration Laboratory including protein quantitation, protein identification, elucidation of complex post-translational modifications and informative data visualizations.
Dr. Ting-Yu Wang
Beckman Institute 201 (ext 2792)
Ting-Yu Wang grew up in Taiwan and obtained his basic training, including bachelor degree (Biological Science and Technology) at National Chiao Tung University and PhD degree (Biotechnology) at National Cheng Kung University, Taiwan. Ting-Yu then did his postdoctoral training with Regius Professor Christopher Secombes at the University of Aberdeen, UK, where he found that lneage/species-specific expansion of the antiviral protein Mx gene family in teleosts. In 2019, he relocated to US as Postdoc in the Section of Immunity and Infection at the University of Southern California and worked with Professor Pinghui Feng to study the mechanism of how SARS-CoV-2 potentially employs immune response to the reprogramming of cellular metabolic processes by using the QExactive Plus Orbitrap LC-MS/MS System. During the training, he was responsible for the development and application of technologies for qualitative and quantitative UPLC-MS/MS proteomic and metabolic analysis. Currently, he works at the PEL on maintenance and operation of mass spectrometers, protein sample preparation, and data analysis.